TG Therapeutics reported 292K in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
TG Therapeutics TGTX:US 292K 144K
Abbvie ABBV:US $ 4341M 157M
Amgen AMGN:US $ 1609M 28M
Ardelyx ARDX:US $ 0M 0M
Bayer BAYN:GR € 3887M 659M
Biogen BIIB:US $ 511.8M 52.1M
Corcept Therapeutics CORT:US $ 1.27M 0.11M
Curis CRIS:US $ 0.15M 0.04M
Dynavax Technologies DVAX:US $ 60.09M 45.24M
Gilead Sciences GILD:US $ 1223M 167M
Infinity Pharmaceuticals INFI:US $ 0.26M 0.05M
Intercept Pharmaceuticals ICPT:US $ 0.66M 0.04M
Johnson & Johnson JNJ:US $ 7250M 317M
Karyopharm Therapeutics KPTI:US $ 589K 549K
Novartis NOVN:VX SF 3848M 94M
Ptc Therapeutics PTCT:US $ 6.54M 0.82M
Puma Biotechnology PBYI:US $ 10.28M 1.69M
Regeneron Pharmaceuticals REGN:US $ 453.2M 240.5M
Verastem VSTM:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 236.51M 8.54M